The Development And Validation Of A Novel Genetic-Based Warfarin Dosing Nomogram

The Development And Validation Of A Novel Genetic-Based Warfarin Dosing Nomogram

Bibliographic Details
Main Author:	Kidd, Robert Scott
Language:	English
Published:	The Ohio State University / OhioLINK 2008
Subjects:	Genetics Pharmaceuticals Pharmacology warfarin CYP2C9 VKOR pharmacogenetics
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1216306028

Similar Items

On the Prediction of Warfarin Dose
by: Eriksson, Niclas
Published: (2012)

Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
by: Jinhua Zhang, et al.
Published: (2020-01-01)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
by: Nita A Limdi, et al.
Published: (2012-10-01)

Pharmacogenetic Warfarin Dosing Algorithm in the Russian Population
by: T. A. Bairova, et al.
Published: (2019-07-01)

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin
by: O. A. Panibratiuk, et al.
Published: (2020-06-01)

Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians
by: Utama Andi, et al.
Published: (2011-06-01)

Should We Routinely Screen for Warfarin Gene Polymorphism in Patients with Coumadin Overdose?
by: Enes Elvin Gül, et al.
Published: (2016-12-01)

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
by: Letícia C. Tavares, et al.
Published: (2018-05-01)

Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolism
by: Johnson, Sara W, et al.
Published: (2011-02-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

Impact of <i>CYP2C9</i> and <i>VKORC1</i> Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy
by: Laith N. AL-Eitan, et al.
Published: (2018-11-01)

Association between Cytochrome P450 2 C9 and Vitamin K Epoxide Reductase Complex Subunit 1 Polymorphisms with Warfarin dose among Iranian Patients
by: Reyhaneh Kameli, et al.
Published: (2016-11-01)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
by: Eljilany I, et al.
Published: (2021-08-01)

Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature
by: Salem M, et al.
Published: (2021-01-01)

Étude pharmacogénomique sur l’utilisation de la warfarine en pratique clinique réelle
by: Marin-Leblanc, Mélina
Published: (2011)

Étude pharmacogénomique sur l’utilisation de la warfarine en pratique clinique réelle
by: Marin-Leblanc, Mélina
Published: (2011)

Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans
by: Assaf Gottlieb, et al.
Published: (2017-11-01)

Frequencies of polymorphisms in genes affecting the pharmacokinetics of warfarin in the Zaporizhzhia region
by: M. Yu. Kolesnik, et al.
Published: (2021-07-01)

Rôles des polymorphismes génétiques dans la détermination de la dose individuelle de la warfarine chez les patients traités avec de l’amiodarone
by: Bahroun, Imen
Published: (2015)

Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response
by: J. E. Zhang, et al.
Published: (2017-05-01)

Effects of Apatinib on the Pharmacokinetics of Nifedipine and Warfarin in Patients with Advanced Solid Tumors
by: Zhu YT, et al.
Published: (2020-05-01)

GENETIC POLYMORPHISM OF CYTOCHROMES P450 2C9 AND 2C19 IN SLOVENIAN POPULATION
by: Darja Herman, et al.
Published: (2003-06-01)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
by: Abiel Roche-Lima, et al.
Published: (2020-01-01)

Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease
by: AL-Eitan LN, et al.
Published: (2020-11-01)

CYP2C9 Variations and Their Pharmacogenetic Implications Among Diverse South Asian Populations
by: Nizamuddin S, et al.
Published: (2021-01-01)

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial
by: Nicholas L. Syn, et al.
Published: (2018-07-01)

Pharmacogenetics of Anticoagulation and Clinical Events in Warfarin-Treated Patients: A Register-Based Cohort Study with Biobank Data and National Health Registries in Finland
by: Vuorinen AL, et al.
Published: (2021-03-01)

A case of a warfarinized renal cancer patient monitored for prothrombin time-international normalized ratio during methadone introduction
by: Kaoru Yoshioka, et al.
Published: (2017-06-01)

Evaluation of the VKORC 1 and CYP2C9 Gene Polymorphisms and Their Effects on the Emergency Complications in the Patients Using Warfarin
by: Oğuz Yardım, et al.
Published: (2017-06-01)

Supplementation to Improve Anticoagulation Control with Low Dose Vitamin K as an Adjuvant to Warfarin Therapy: A Double-blind, Placebo-controlled Randomized Controlled Trial
by: Majeed, Habeeb
Published: (2012)

Supplementation to Improve Anticoagulation Control with Low Dose Vitamin K as an Adjuvant to Warfarin Therapy: A Double-blind, Placebo-controlled Randomized Controlled Trial
by: Majeed, Habeeb
Published: (2012)

Supplementation to Improve Anticoagulation Control with Low Dose Vitamin K as an Adjuvant to Warfarin Therapy: A Double-blind, Placebo-controlled Randomized Controlled Trial
by: Majeed, Habeeb
Published: (2012)

Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage
by: Natal'ya Mikhaylovna Vorob'eva, et al.
Published: (2011-06-01)

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA
by: D. A. Sychev, et al.
Published: (2015-09-01)

Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study
by: Andrea L. Jorgensen, et al.
Published: (2019-04-01)

Impact of a variable number tandem repeat in the CYP2C9 promoter on warfarin sensitivity and responsiveness in Jordanians with cardiovascular disease
by: AL-Eitan LN, et al.
Published: (2019-03-01)

Pharmacometric Models for Individualisation of Warfarin in Adults and Children
by: Hamberg, Anna-Karin
Published: (2013)

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy
by: Behzad Poopak, et al.
Published: (2016-02-01)

Evaluation of CYP2C9 and VKORC1 gene variants that may result in warfarin dosage sensitivity and poor pregnancy outcomes
by: Mitchell, Cathrine
Published: (2008)

Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease
by: Alghamdi MA, et al.
Published: (2021-03-01)